First-trimester risk factors for preeclampsia development in women initiating aspirin by 16 weeks of gestation

Obstetrics and Gynecology

Volumn 123, Issue 3, 2014, Pages 611-617

  Block Abraham, Dana M ^a   Turan, Ozhan M ^a   Doyle, Lauren E ^a   Kopelman, Jerome N ^a   Atlas, Robert O ^a   Jenkins, Chuka B ^a   Blitzer, Miriam G ^a   Baschat, Ahmet A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ASPIRIN; BLOOD PRESSURE; BODY MASS INDEX; DECISION SUPPORT TECHNIQUES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 84894473650     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000118     Document Type: Article

References (24)

1. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402-14.
2. Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013;41:491-9.
3. Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguère Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009;31:818-26.
4. Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989;321:357-62.
5. Sibai BM, Mirro R, Chesney CM, Leffler C. Low-dose aspirin in pregnancy. Obstet Gynecol 1989;74:551-7.
6. Scholten RR, Hopman MT, Sweep FC, Van de Vlugt MJ, Van Dijk AP, Oyen WJ, et al. Co-occurrence of cardiovascular and prothrombotic risk factors in women with a history of preeclampsia. Obstet Gynecol 2013;121:97-105.
7. Block-Abraham DM, Turan OM, Doyle LE, Kopelman JN, Atlas RO, Jenkins CB, et al. First trimester maternal characteristics, Doppler parameters, and serum analytes after preeclampsia. Hypertens Pregnancy 2013 Dec 4 [Epub ahead of print].
8. Nicolaides KH. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005;29:190-4.
9. Kasdaglis T, Aberdeen G, Turan O, Kopelman J, Atlas R, Jenkins C, et al. Placental growth factor in the first trimester: relationship with maternal factors and placental Doppler studies. Ultrasound Obstet Gynecol 2010;35:280-5.
10. Krantz D, Hallahan T, Ravens R, He K, Cuckle H, Sherwin J, et al. First trimester Down syndrome screening with dried blood spots using a dual analyte free beta hCG and PAPP-A immunofluorometric assay. Prenat Diagn 2011;31:869-74.
11. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No.33 American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;77:67-75.
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
13. Vainio M, Kujansuu E, Iso-Mustajarvi M, Mäenpää J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002;109:161-7.
14. Kannel WB, Wolf PA. Framingham Study insights on the hazards of elevated blood pressure. JAMA 2008;300:2545-7.
15. Liszka HA, Mainous AG 3rd, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann Fam Med 2005;3:294-9.
16. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997; 177:1003-10.
17. Gordon M. Maternal physiology. In: Gabbe S, Niebyl J, Simpson J, Landon M, Galan H, Jauniaux E, editors. Obstetrics: normal and problem pregnancies. 6th ed. Philadelphia (PA): Elsevier Saunders; 2012. p. 42-65.
18. Hermida RC, Ayala DE, Iglesias M. Administration timedependent influence of aspirin on blood pressure in pregnant women. Hypertension 2003;41:651-6.
19. Hermida RC, Ayala DE, Fernandez JR, Mojon A, Alonso I, Silva I, et al. Administration time-dependent effects of aspirin in women at differing risk for preeclampsia. Hypertension 1999;34:1016-23.
20. Kannel WB. Hypertension: reflections on risks and prognostication. Med Clin North Am 2009;93:541-58.
21. Kannel WB. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000;13: 3-10S.
22. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-8.
23. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-53.
24. Sibai BM. Caring for women with hypertension in pregnancy. JAMA 2007;298:1566-8.